Stock listing
A2ACSB Stock Price, News, Filings & Events — Genscript Biotech Corporation
Selected listing: A2ACSB · LS · EUR · DE
This page tracks Genscript Biotech Corporation's A2ACSB:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A2ACSB:LS. A2ACSB:LS is the stock-level entry point for investors researching Genscript Biotech Corporation, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- A2ACSB:LS
- Asset type
- Stock
- Market cap
- $9.89B
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- LS
- Currency
- EUR
Genscript Biotech Corporation A2ACSB:LS stock context
This page tracks Genscript Biotech Corporation's A2ACSB:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A2ACSB:LS. A2ACSB:LS is the stock-level entry point for investors researching Genscript Biotech Corporation, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Genscript Biotech Corporation
GenScript Reports 27.3% First-Half 2026 Revenue Growth as AI Drug Discovery Business Doubles
August 18, 2026
GenScript Sets New Benchmark for Responsible Biotech Leadership with 2025 ESG Report
April 14, 2026
GenScript and Mimulus Partner to Industrialize DNA-Based Data Storage for the AI Era
April 9, 2026
GenScript Biotech Corp Reports Strong FY2025 Results as Integrated Platform Strategy and Global Execution Drive High-Quality Growth
March 16, 2026
GenScript Biotech Global Forum, "Scripting Possibilities", Convened AI and Biopharma Leaders in San Francisco
January 29, 2026
Genscript Biotech Corporation earnings calls
Research Genscript Biotech Corporation
Genscript Biotech Corporation investor report
Review AI stock analysis and investor report context for A2ACSB:LS.
Genscript Biotech Corporation company profile
View the public company page for Genscript Biotech Corporation on 6ix.
Genscript Biotech Corporation news
Read company news and market updates connected to Genscript Biotech Corporation.
Genscript Biotech Corporation investor events
Find investor webinars, events, and replay context for Genscript Biotech Corporation.
Alternate listings
1548:HKEX
HK · HKD
Alternate listing for Genscript Biotech Corporation; the primary context on this page is A2ACSB:LS.
G51:GETTEX
DE · EUR
Alternate listing for Genscript Biotech Corporation; the primary context on this page is A2ACSB:LS.
GNNSF:OTC
US · USD
Alternate listing for Genscript Biotech Corporation; the primary context on this page is A2ACSB:LS.
A2ACSB:LSX
DE · EUR
Alternate listing for Genscript Biotech Corporation; the primary context on this page is A2ACSB:LS.
G51:TRADEGATE
DE · EUR
Alternate listing for Genscript Biotech Corporation; the primary context on this page is A2ACSB:LS.
G51:FWB
DE · EUR
Alternate listing for Genscript Biotech Corporation; the primary context on this page is A2ACSB:LS.
G51:SWB
DE · EUR
Alternate listing for Genscript Biotech Corporation; the primary context on this page is A2ACSB:LS.
G51:DUS
DE · EUR
Alternate listing for Genscript Biotech Corporation; the primary context on this page is A2ACSB:LS.
G51:MUN
DE · EUR
Alternate listing for Genscript Biotech Corporation; the primary context on this page is A2ACSB:LS.